Elysium Pharmaceuticals Limited Docusate Export Data — India (DGFT 2022–2026)

Name: Elysium Pharmaceuticals Limited Docusate Export Records India — #11 Exporter, 3 Shipments, $44.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docusate

India Pharmaceutical Trade Intelligence

$9.3M25 Suppliers35 CountriesHS 30049039

ExportsIndia → UNITED STATES84.6%India → AUSTRALIA12.9%

ImportsUNITED KINGDOM → India$324 JAPAN → India$71

#1 Supplier: TRUECARE BIOMEDIX #1 Buyer: PL DEVELOPMENTS

Elysium Pharmaceuticals Limited — Docusate Exporter #11 | $292.3K Trade Value | TransData Nexus | TransData Nexus

Elysium Pharmaceuticals Limited — Docusate Exporter Profile

Indian Pharmaceutical Exporter · #11 for Docusate · $292.3K export value · DGFT Verified

Elysium Pharmaceuticals Limited is the #11 Indian exporter of Docusate with $292.3K in export value and 3 verified shipments. Elysium Pharmaceuticals Limited holds a 2.7% market share in Docusate exports across 1 countries. The company exports 9 pharmaceutical products worth $70.1M across 5 therapeutic categories.

Elysium Pharmaceuticals Limited — Docusate Export Profile: Buyers & Destinations

Elysium Pharmaceuticals Limited Docusate export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Docusate?

Country	Value	Shipments	Share
UNITED STATES	$7.8M	234	84.6%
AUSTRALIA	$1.2M	81	12.9%
CANADA	$134.6K	12	1.5%
VENEZUELA	$28.3K	1	0.3%

Who Are the Top Buyers of Docusate from India?

Buyer	Country	Value	Orders
PL DEVELOPMENTS	UNITED STATES	$5.0M	99
GERICARE PHARMACEUTICALS CORP.	UNITED STATES	$1.2M	32
GENERIC HEALTH	AUSTRALIA	$371.2K	11
APOTEX AUSTRALIA	AUSTRALIA	$329.2K	34
GERICARE PHARMACEUTICALS CORP	UNITED STATES	$300.0K	6
NOUMED PHARMACEUTICALS PTY LTD	AUSTRALIA	$172.6K	10
NOUMED PHARMACEUTICALS PTY LIMITED	AUSTRALIA	$148.3K	12
GERICARE PHARMACEUTICALS	UNITED STATES	$145.8K	6
STRIVE PHARMACEUTICALS	UNITED STATES	$141.3K	8
PRIVATE LIMITED DEVELOPMENTS	UNITED STATES	$100.0K	2

India's Docusate is purchased by 158 buyers worldwide. The top buyer is PL DEVELOPMENTS (UNITED STATES), followed by GERICARE PHARMACEUTICALS CORP. and GENERIC HEALTH.

How Does Elysium Pharmaceuticals Limited Compare to Nearest Docusate Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	MARKSANS PHARMA LIMITED	$102.5K	6	1	$17.1K
10	SOFTGEL HEALTHCARE PRIVATE LIMITED	$48.9K	4	1	$12.2K
11	ELYSIUM PHARMACEUTICALS LIMITED ★	$44.1K	3	1	$14.7K

Elysium Pharmaceuticals Limited ranks #11 among 25 Indian Docusate exporters. Average shipment value of $14.7K compared to the market average of $353.6K. The closest competitors by value are MARKSANS PHARMA LIMITED and SOFTGEL HEALTHCARE PRIVATE LIMITED.

Which Indian Ports Ship Docusate Exports?

Port	Shipments	% Share
SAHAR AIR	79	17.4%
MUNDRA SEA	68	15.0%
MUNDRA SEA (INMUN1)	50	11.0%
SAHAR AIR CARGO ACC (INBOM4)	48	10.6%
Bombay Air	20	4.4%
JNPT	17	3.8%
JNPT/ NHAVA SHEVA SEA	17	3.8%
AHEMDABAD ICD	16	3.5%

Geopolitical & Trade Policy Impact on Elysium Pharmaceuticals Limited's Docusate Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Elysium Pharmaceuticals. The Israel-Iran conflict has led to disruptions in the Red Sea shipping routes, causing a 30% reduction in business volume and doubling transit times for Indian pharma exports. Shipping surcharges have escalated from $450 to $12,000 per container, significantly impacting export costs. (sidvim.com)

Conversely, US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. India's established reputation as the "pharmacy of the world," supplying around 40% of generic demand in the US, positions companies like Elysium to capitalize on this shift. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) necessitates unique identifier codes on API shipments, adding $0.50–$0.80 per kilogram in tracking costs. For Elysium, ensuring adherence to such regulations is crucial to maintain and expand their presence in the EU market. (pmarketresearch.com)

Elysium Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Elysium Pharmaceuticals' commitment to quality is evident through its accreditations from the USFDA, Health Canada, and WHO-GMP. These certifications not only facilitate access to regulated markets but also instill confidence among global partners. (elysiumpharma.com)

The Indian pharmaceutical industry has faced scrutiny over quality control issues, with instances of counterfeit medications and regulatory non-compliance. In response, the Indian government has intensified efforts to strengthen its National Quality Infrastructure (NQI) and align with international standards. For exporters like Elysium, maintaining rigorous quality assurance systems is imperative to navigate the evolving regulatory landscape and uphold their market reputation. (en.wikipedia.org)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docusate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Elysium Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 35+ countries, 158+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docusate

Docusate

Elysium Pharmaceuticals Limited — Docusate Exporter Profile

Elysium Pharmaceuticals Limited — Docusate Export Profile: Buyers & Destinations

Where Does India Export Docusate?

Who Are the Top Buyers of Docusate from India?

What Is India's Total Docusate Export Value and How Much Does Elysium Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Elysium Pharmaceuticals Limited's Docusate Exports?

How Does Elysium Pharmaceuticals Limited Compare to Other Indian Docusate Exporters?

Regulatory Requirements: Exporting Docusate to Key Markets

United States — FDA

Australia — TGA

How Does Elysium Pharmaceuticals Limited Compare to Nearest Docusate Exporters?

Which Indian Ports Ship Docusate Exports?

Geopolitical & Trade Policy Impact on Elysium Pharmaceuticals Limited's Docusate Exports

Elysium Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Elysium Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docusate Export Data from Elysium Pharmaceuticals Limited

Docusate Stats

Company Overview

Top Products by Elysium Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source